arrow
M

Matthew M. Miele

US FDA
H指数:12
被引数:2,846

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers

NR2F2的抑制恢复了内分泌耐药性乳腺癌对激素治疗的反应

2025-01-010
OA
HLA-independent T cell receptors for targeting tumors with low antigen density
2022-01-1398
OA
HLA-INDEPENDENT T CELL RECEPTORS EFFECTIVELY TARGET LOW ABUNDANCE ANTIGENS
2021-11-100
OA
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

Car-t细胞靶向递送PD-1-blocking scFv增强体内抗肿瘤功效

2018-10-01655
OAAI